In KMT2A‐ as well as NUP98‐rearranged leukemia unbiased CRISPR‐Cas9 screens have revealed that loss of PRC1.1 function renders leukemia cells resistant to Menin inhibition.108, 110, 111, 112. This evidence concerns the gene MEN1 and leukemia.